Stachys sieboldii Extract Supplementation Attenuates Memory Deficits by Modulating BDNF-CREB and Its Downstream Molecules, in Animal Models of Memory Impairment

Nutrients
Vijaya Abinaya RavichandranYoun Soo Cha

Abstract

Cholinergic dysfunction, impaired brain-derived neurotrophic factor and cAMP response element binding protein (BDNF-CREB) signaling are one of the major pathological hallmarks of cognitive impairment. Therefore, improving cholinergic neurotransmission, and regulating the BDNF-CREB pathway by downregulating apoptosis genes is one strategy for inhibiting the etiology of dementia. This study evaluates the potential effects of Stachys sieboldii MIQ (SS) extract against cognitive dysfunction and its underlying mechanisms. SS supplementation for 33 days improved scopolamine-induced memory impairment symptoms in Morris water maze test and Y-maze test. SS reduced the acetylcholineesterase activity and significantly increase acetylcholine and cholineacetyltransferase activity in the brain. In the subsequent mechanism study, SS regulated the mRNA expression level of neuronal plasticity molecules such as (nerve growth factor) NGF, BDNF, CREB, and its downstream molecules such as Bcl-2 and Egr-1 by downregulating the neuronal apoptosis targets in both hippocampus and frontal cortex. Additionally, inward currents caused by SS in hippocampal CA1 neurons was partially blocked by the GABA receptor antagonist picrotoxin (50 μM), suggesting that...Continue Reading

References

Jan 1, 1991·Phytochemistry·H NishimuraH Mitsuhashi
Dec 1, 1990·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·J YamaharaY Kawahara
May 1, 1984·Journal of Neuroscience Methods·R Morris
Apr 4, 2003·The New England Journal of Medicine·Robert M Friedlander
Apr 30, 2003·Journal of Pharmacological Sciences·Kiyofumi Yamada, Toshitaka Nabeshima
Oct 6, 2005·Learning & Memory·Mariana AlonsoJorge H Medina
Aug 31, 2006·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Louis F Reichardt
Dec 21, 2006·Advances in Pharmacology·Graham A R JohnstonKenneth N Mewett
Mar 14, 2008·Behavioural Brain Research·Rahul AgrawalChandishwar Nath
Nov 7, 2008·Expert Review of Neurotherapeutics·Elliott J MufsonStephen D Ginsberg
Sep 4, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·James M ConnerMark H Tuszynski
Dec 5, 2009·Cell Death and Differentiation·M D'AmelioF Cecconi
Jan 22, 2010·PloS One·María-Salud García-AyllónJavier Sáez-Valero
May 4, 2012·Cold Spring Harbor Perspectives in Medicine·Rawan Tarawneh, David M Holtzman
May 16, 2012·Molecular Brain·Zheng Li, Morgan Sheng
May 29, 2013·The American Journal of Chinese Medicine·Janardhan Prasad BhattaraiSeong Kyu Han
Jan 28, 2015·Journal of Ayurveda and Integrative Medicine·Janardhan Prasad Bhattarai, Seong Kyu Han
Jan 4, 2017·European Journal of Epidemiology·Marco CanevelliMatteo Cesari
Jan 20, 2017·Dementia and Geriatric Cognitive Disorders Extra·Ericksen Mielle BorbaMárcia Lorena Fagundes Chaves

❮ Previous
Next ❯

Citations

Oct 3, 2020·Medicines·Ekaterina-Michaela TomouHelen Skaltsa
Sep 17, 2020·Immunology·Qiaohui ZhangYibo Tang

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

SPSS
Ethovision
Clampex

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis